Attitudes of men in an Australian male tolerance study towards microbicide use

被引:14
作者
Holmes, Wendy R. [1 ]
Maher, Lisa [2 ]
Rosenthal, Susan L. [3 ,4 ]
机构
[1] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia
[2] St Vincents Hosp & Med Ctr, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia
[3] Univ Texas Galveston, Med Branch, Dept Pediat, Galveston, TX 77555 USA
[4] Univ Texas Galveston, Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
关键词
acceptability; sexuality;
D O I
10.1071/SH07093
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Vaginal microbicides are in development to provide new options for the prevention of sexually transmissible infections. Although promoted as a female-initiated product, men may influence the decision to use a microbicide and the way that it is used, so it is important to explore their views. Methods: Men (n = 36) enrolled in a 7-day, phase 1 clinical safety trial of SPL7013 Gel were interviewed pre- and post-use of the gel. The trial did not include use of the gel during sex. Interviews were digitally-recorded and transcribed verbatim, and analysed using a framework approach. Results: The men (mean age 37 years) were interested in the idea of vaginal microbicides, had little knowledge about them, and varied beliefs about how they work. They tended to assess microbicide use in relation to condoms and lubricants. Many would want a microbicide to be as effective as condoms. Participants did not anticipate difficulties discussing use with their partners. Many thought that a microbicide would be less intrusive than condoms; some anticipated that the lubricating properties might enhance sexual pleasure. Some anticipated using a microbicide with a condom or with a lubricant, and a few raised questions about the timing of use and use during different types of sexual activity. Conclusions: No major barriers to microbicide use were found in this sample of Australian men, who anticipated being willing to use them if they are shown to be safe and effective. Our findings should help to inform the design of further studies as well as future information materials and anticipatory guidance.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 35 条
[11]  
de Visser RO, 2003, AUST NZ J PUBL HEAL, V27, P146, DOI 10.1111/j.1467-842X.2003.tb00802.x
[12]   CONTRACEPTIVE EFFICACY AND ACCEPTABILITY OF THE FEMALE CONDOM [J].
FARR, G ;
GABELNICK, H ;
STURGEN, K ;
DORFLINGER, L .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (12) :1960-1964
[13]  
FLOOD M, 2003, IMPACT, V4, P10
[14]   Shifts in condom use following microbicide introduction: should we be concerned? [J].
Foss, AM ;
Vickerman, PT ;
Heise, L ;
Watts, CH .
AIDS, 2003, 17 (08) :1227-1237
[15]   A CROSS-SECTIONAL SURVEY OF CONDOM USE IN CONJUNCTION WITH OTHER CONTRACEPTIVE METHODS [J].
FRANK, ML ;
POINDEXTER, AN ;
COX, CA ;
BATEMAN, L .
WOMEN & HEALTH, 1995, 23 (02) :31-46
[16]   Heterosexual anal intercourse: Prevalence, cultural factors, and HIV infection and other health risks, Part I [J].
Halperin, DT .
AIDS PATIENT CARE AND STDS, 1999, 13 (12) :717-730
[17]  
Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454
[18]   Biomedical HIV prevention - and social science [J].
Imrie, John ;
Elford, Jonathan ;
Kippax, Susan ;
Hart, Graham J. .
LANCET, 2007, 370 (9581) :10-11
[19]  
Keogh L A, 2005, Sex Health, V2, P109, DOI 10.1071/SH04023
[20]   Famciclovir reduces viral mucosal shedding in HSV-Seropositive persons [J].
Leone, Peter ;
Warren, Terri ;
Hamed, Kamal ;
Fife, Kenneth ;
Wald, Anna .
SEXUALLY TRANSMITTED DISEASES, 2007, 34 (11) :900-907